BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21247585)

  • 1. Myoepithelial cell layer integrity in canine mammary carcinoma.
    Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
    J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
    Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
    Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CD10 as a marker of canine mammary myoepithelial cells.
    Sánchez-Céspedes R; Suárez-Bonnet A; Millán Y; Guil-Luna S; Reymundo C; Herráez P; Espinosa de Los Monteros A; Martin de Las Mulas J
    Vet J; 2013 Feb; 195(2):192-9. PubMed ID: 22819182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium.
    Espinosa Los de Monteros A; Millán MY; Ordás J; Carrasco L; Reymundo C; Martín Las de Mulas J
    Vet Pathol; 2002 Mar; 39(2):247-56. PubMed ID: 12009063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
    Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
    J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of class II beta-tubulin by proliferative myoepithelial cells in canine mammary mixed tumors.
    Arai K; Nakano H; Shibutani M; Naoi M; Matsuda H
    Vet Pathol; 2003 Nov; 40(6):670-6. PubMed ID: 14608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system.
    Sánchez-Céspedes R; Maniscalco L; Iussich S; Martignani E; Guil-Luna S; De Maria R; Martín de Las Mulas J; Millán Y
    Vet J; 2013 Aug; 197(2):474-82. PubMed ID: 23583698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
    Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
    J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
    Ressel L; Millanta F; Poli A
    J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis.
    Gärtner F; Geraldes M; Cassali G; Rema A; Schmitt F
    Vet J; 1999 Jul; 158(1):39-47. PubMed ID: 10409415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.